40
Participants
Start Date
November 30, 2024
Primary Completion Date
October 31, 2025
Study Completion Date
April 30, 2026
Product X
The investigational device is a polyethylene glycol-based biomaterial. It can be applied to donor sites on the arms, torso, and legs.
Standard-of-Care
The active comparator includes the current standard-of-care treatment: hydrocellular polyurethane dressing covered with TegadermTM film for 48 hours, followed by an occlusive gauze impregnated with 3% Bismuth Tribromorphenate in petrolatum.
Hamilton General Hospital, Hamilton
Hamilton Health Sciences Corporation
OTHER